Evolus Advances Mid-Face Filler Toward FDA Approval
Evolus has submitted the final module of its PMA application to the FDA for Evolysse Sculpt, an injectable HA gel for mid-face volume restoration.
Evolus has submitted the final module of its PMA application to the FDA for Evolysse Sculpt, an injectable HA gel for mid-face volume restoration.
Research suggests patients using medical weight loss drugs are increasingly seeking treatments for facial volume loss and other appearance changes.